C-peptide ELISA
C-peptide ELISA
(10-1136-01)
Kit format: 1 x 96 wells
Measurement range: 100 - 4000 pmol/L (0.302 - 12.1 µg/L)
No or minimal cross-reactivity to human insulin and proinsulin
High specificity enables measurement of human C-peptide in mouse and rat models
CE/IVD labeled on selected markets
Serum controls available: 10-1134-01 (US only) or 10-1164-01
The C-peptide ELISA is a high quality immunoassay for specific quantification of human C-peptide in serum, plasma or urine
The Mercodia C-peptide ELISA is a highly specific tool registered for in vitro diagnostics (IVD) use. It is calibrated against the International Reference Reagent for human C-peptide, IRR84/510. The specificity of the utilized antibodies enables measurement of human C-peptide without interference from insulin or proinsulin, and measurement of human C-peptide in mouse and rat models.
Each Mercodia C-peptide ELISA kit contains reagents for 96 wells, sufficient for 42 samples and one calibrator curve in duplicate. The microplate strip format (12 strips x 8 wells) is ideal when only a limited number of samples need to be analyzed.
Mercodia Diabetes Antigen Control (10-1134-01 (US only) or 10-1164-01) is designed to be used as a two-level control for human C-peptide.
Human
Serum, EDTA and heparin plasma or urine
25 µL
100-4000 pmol/L (0.3-12.0 ng/mL)
≤ 25 pmol/L (0.076 μg/L)
1h + 1h + 15 min
Absorbance
The following cross-reactions have been tested:
< 0.0006 %
2 %
3 %
2 %
74 %
10 %
| LOT. NO. | DOCUMENT |
|---|---|
| 36946 | DfU - 10-1136-01 v. 16.0 |
| 36718 | DfU - 10-1136-01 v. 16.0 |
| 36553 | DfU - 10-1136-01 v. 16.0 |
| 36410 | DfU - 10-1136-01 v. 16.0 |
| 36271 | DfU - 10-1136-01 v. 16.0 |
| 36106 | DfU - 10-1136-01 v. 16.0 |
| 35992 | DfU - 10-1136-01 v. 16.0 |
| 35702 | DfU - 10-1136-01 v. 16.0 |
| 35515 | DfU - 10-1136-01 v. 16.0 |
| LOT. NO. | DOCUMENT |
|---|---|
| 36946 | CoA - 10-1136-01 |
| 36718 | CoA - 10-1136-01 |
| 36553 | CoA - 10-1136-01 |
| 36410 | CoA - 10-1136-01 |
| 36271 | CoA - 10-1136-01 |
| 36106 | CoA - 10-1136-01 |
| 35992 | CoA - 10-1136-01 |
| 35702 | CoA - 10-1136-01 |
| 35515 | CoA - 10-1136-01 |
For other languages and previous versions: Technical Library
Tatovic, D. et al. (2016) Stimulated urine C-peptide creatinine ratio vs serum C-peptide level for monitoring of β-cell function in the first year after diagnosis of Type 1 diabetes. Diabet. Med. 33, 1564–1568. Read more >
Honsek, C. et al. (2018) Fibre supplementation for the prevention of type 2 diabetes and improvement of glucose metabolism: the randomised controlled Optimal Fibre Trial (OptiFiT). Diabetologia 61, 1295–1305. Read more >
Kondo, Y. et al. (2017) Identification of a small molecule that facilitates the differentiation of human iPSCs/ESCs and mouse embryonic pancreatic explants into pancreaticendocrine cells. Diabetologia 60, 1454–1466. Read more >
Li, J. et al. (2019) Evaluation of [68Ga]DO3A-VS-Cys40-Exendin-4 as a PET Probe forImaging Human Transplanted Islets in the Liver. Sci. Rep. 9, 5705. Read more >
Question about the product? Contact us
Customer Success Manager & Area Sales Manager Nordics
robert.almstedt@mercodia.com (+46) 72 292 15 08